Novartis N
NOVN
CHF
STOCK MARKET:
SWX
Open
 
...
Price in deferred time of 15 minutes
Last quote
05/20/2022 - 15:42:22
Bid
05/20/2022 - 15:42:26
Bid
Volume
Ask
05/20/2022 - 15:42:26
Ask
Volume
86.60
+0.91 ( +1.06% )
86.60
297
86.61
409
More information
Analysis by TheScreener
17.05.2022
Evaluation Slightly positive  
Interest Very strong  
Sensibility Low  
Analysis date: 17.05.2022
Global Evaluation
  Slightly positive
The stock is classified in the slightly positive zone since 06.05.2022.
Interest
  Very strong
Very strong interest since 10.05.2022.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 10.05.2022 at a price of 83.91.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly undervalued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 18.03.2022. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 82.859.
4wk Rel Perf
  4.58%
 
The four week relative overperformance versus STOXX600 is 4.58%.
Sensibility
  Low
The stock has been on the low-sensitivity level since 26.04.2022.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.56%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 1.05%.
Mkt Cap in $bn
  211.62
With a market capitalization >$8bn, NOVARTIS AG is considered a large-cap stock.
G/PE Ratio
  1.11
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  12.32
The estimated PE is for the year 2024.
LT Growth
  9.91%
The annualized growth estimate is for the current year to 2024.
Avg. Nb analysts
  26
Over the last seven weeks, an average of 26 analysts provided earnings per share estimates.
Dividend Yield
  3.77%
The twelve month estimated dividend yield represents 46.49% of earnings forecasts.
Beta
  62
For 1% of index variation, the stock varies on average by 0.62%.
Correlation
  0.55
54.69% of stock movements are explained by index variations.
Value at Risk
  6.47
The value at risk is estimated at CHF 6.47. The risk is therefore 7.40%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.01.2002